Filter your results
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapsesOncotarget, 2016, 7 (51), pp.83987-84002. ⟨10.18632/oncotarget.9793⟩
Journal articles
hal-02314515v1
|
||
|
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapyAmerican Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
Journal articles
hal-03401859v1
|
||
|
BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.Modern Pathology, 2012, 25 (6), pp.805-14. ⟨10.1038/modpathol.2012.1⟩
Journal articles
inserm-00682931v1
|